Stilbene Biopharma Ltd

Company Description

In construction industry we play an important role, given the quality of our Tacrolimus prevailing in the market. Our production facility was first launched with US$10 Million - US$50 Million of initial capital and now takes care of Tacrolimus manufacturing with skilled workforce and technologically advanced equipment, as a reputable Manufacturer would do. In addition, we hold Australia,Canada,Germany,India,Norway export share across borders, thanks to our aesthetically appealing and durable Tacrolimus. We are enlisted among top Exporter of NEW DELHI, , India, owing to our Tacrolimus, being top choice in the construction supplies market. Stilbene Biopharma Ltd Private Limited has reached annual revenue scale across Approx 0.5 Billion US Dollar, based on our successful 18 Years of export history. Our product range is specifically designed to level up architecture not only in terms of appeal but also a make that commits years of service. Since, 2002 our products have been remarkable helping us reach a quite fruitful export ratio value estimating around US$10 Million - US$50 Million.